CORRESP Filing
PAVmed Inc.
Date: April 15, 2025 · CIK: 0001624326 · Accession: 0001641172-25-004716
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286442
Letter
PAVmed Inc.
Madison Avenue, 25th Floor
New York, New York 10017
April 15, 2025
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
F Street, N.E.
Washington, D.C. 20549
Attention: Robert Augustin
Re:
PAVmed Inc. Registration Statement on Form S-3 Filed April 8, 2025 File No. 333-286442
Ladies and Gentlemen:
PAVmed Inc. hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 9:30 a.m., Thursday, April 17, 2025, or as soon thereafter as practicable.
Very truly yours,
PAVMED INC.
Show Raw Text
CORRESP 1 filename1.htm PAVmed Inc. 360 Madison Avenue, 25th Floor New York, New York 10017 April 15, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Robert Augustin Re: PAVmed Inc. Registration Statement on Form S-3 Filed April 8, 2025 File No. 333-286442 Ladies and Gentlemen: PAVmed Inc. hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 9:30 a.m., Thursday, April 17, 2025, or as soon thereafter as practicable. Very truly yours, PAVMED INC. By: /s/ Lishan Aklog, M.D. Name: Lishan Aklog, M.D. Title: Chairman and Chief Executive Officer